WIN-Partners Co., Ltd. (WIN-PARTNERS CO LTD) aksje
3183.T
StengtWIN-PARTNERS CO LTD
Market Cap
$32,668,616,704
Om WIN-Partners Co., Ltd. (WIN-PARTNERS CO LTD) aksje
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous coronary intervention products, including PTCA balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment. WIN-Partners Co., Ltd. was founded in 1983 and is headquartered in Tokyo, Japan.
Selskapsinformasjon
104-0031 Tokyo, Japan
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.